Belgium's Gimv sells remaining Ablynx stake

BRUSSELS Thu Oct 17, 2013 12:11pm EDT

BRUSSELS Oct 17 (Reuters) - Belgian investment fund Gimv said it sold its remaining stake in biotech firm Ablynx after partnering the company for 12 years.

Gimv said the exit has a positive impact of 3.8 million euros on its last published equity value, and it would use the proceeds to make other investments in the biotech sector. (Reporting by Robert-Jan Bartunek)